Multiple sclerosis is an inflammatory demyelinating disease of the central nervous system (CNS) that affects an estimated 350,000 people in the United States and some 2.5 million worldwide 1 . Experimental autoimmune encephalomyelitis (EAE) is the most commonly used animal model of multiple sclerosis. Studies using the EAE model have helped to define the sequence of immunopathogenic events in the development of autoimmune CNS-directed inflammatory disease 2 . During the initiation stage of EAE, CNS antigen-reactive T cells undergo activation and clonal expansion in the secondary lymphoid organs while antigen-presenting cells produce cytokines that regulate the differentiation of effector CD4 + T cells, skewing those cells toward classical type 1 helper T (T H 1) cell (producing interferon-γ (IFN-γ)) and interleukin 17 (IL-17)-producing helper T (T H 17) cell (producing IL-17, IL-21, the cell-signaling molecule GM-CSF and tumor necrosis factor (TNF)) lineages. Data demonstrate that both T H 1 cells and T H 17 cells are able to independently induce EAE, possibly through different mechanisms [3] [4] [5] [6] .
T H 17 cells are generated as a discrete lineage when the peripheral priming microenvironment contains IL-6 and the morphogen TGF-β, and they seem to acquire encephalitogenic potential after reactivation and proliferation in the presence of IL-1β and IL- 23 (refs. 7-9) . We, along with others, have reported that expression of the IL-1 receptor (IL-1R) is strongly induced during T H 17 cell differentiation 10, 11 . Mice deficient in IL-1R have shown significant reductions in EAE disease severity, whereas mice deficient in IL-1Ra, the endogenous soluble IL-1R antagonist, were shown to have worse disease than wild-type controls 10, 12, 13 . IL-1β stimulation of T H 17 cells leads to strong and prolonged activation of the mammalian target of rapamycin (mTOR) pathway, which has a critical role in cell proliferation and survival and is required for T H 17 cell-dependent EAE pathogenesis 14, 15 .
The NLRP3 inflammasome consists of the cytoplasmic receptor NLRP3 linked via a homotypic pyrin domain interaction to the inflammasome adaptor molecule apoptosis-associated speck-like protein containing a C-terminal caspase-activation and recruitment (CARD) domain (ASC). ASC interacts with pro-caspase-1 via a CARD domain, resulting in activation and maturation of caspase-1 and production of IL-1β and IL-18. Several independent studies have recently reported a critical role for the NLRP3 inflammasome [16] [17] [18] . However, the spatiotemporal role and cellular source of IL-1β during EAE pathogenesis are poorly defined. Although many previous studies have reported that ASC-dependent inflammasome signaling mediates T cell function during both host defense and autoimmune processes, it has remained unclear whether ASC has any T cell-intrinsic role.
Here we report that the inflammasome adaptor molecule ASC has a critical T cell-intrinsic role in the pathogenesis of T H 17 cell-mediated EAE. We observed that T cell-intrinsic ASC was required for the effector stage of EAE, and ASC deficiency in T cells impaired T H 17 cell-mediated but not T H 1 cell-mediated EAE. Mechanistically, T cell antigen receptor (TCR) activation induced pro-IL-1β expression and nuclear-to-cytosolic translocation of ASC; polarized T H 17 cells expressed IL-1R, and they produced mature IL-1β in response to ATP via ASC-and NLRP3-dependent caspase-8 activation. ATP-treated T H 17 cells showed enhanced survival compared with ATP-treated T H 1 cells, which was abrogated by IL-1Ra, suggesting an autocrine action of T H 17 cell-derived IL-1β. Together these data suggest a critical role for IL-1β produced by a previously unrecognized T H 17 cell-intrinsic ASC-NLRP3-caspase-8 inflammasome during CNS inflammation.
RESULTS
T cell-specific ASC deficiency delayed and greatly attenuated EAE To investigate whether ASC has any T cell-intrinsic role, we bred a mouse strain in which all three exons of the gene Pycard (which encodes ASC) are flanked by loxP sites (Asc f/f mice) onto the Lck-Cre transgenic mouse strain, which expresses Cre under the control of the Lck proximal promoter, generating Asc f/+ Lck-Cre mice ( Fig. 1a and Supplementary Fig. 1 ). We generated mice with T cell-specific deletion of Pycard by further cross-breeding to obtain Asc f/− Lck-Cre and littermate control Asc f/+ Lck-Cre mice (Supplementary Fig. 2) . We tested the effect of T cell-specific Pycard deletion on neuroinflammation and demyelination by immunizing Asc f/− Lck-Cre and littermate control Asc f/+ Lck-Cre mice with the neuroantigen MOG peptide. Mice with T cell-specific ASC deficiency had attenuated disease severity compared with controls (Fig. 1b) . Pycard +/+ and Pycard +/− mice had similar EAE phenotypes after immunization (data not shown), which indicated that haploinsufficiency of Pycard has no effect on EAE phenotype. Whereas Asc f/+ Lck-Cre mice developed severe EAE, Asc f/f Lck-Cre mice were protected, mirroring the data shown in Figure 1b (data not shown). Inflammatory mononuclear cell infiltration in the brain, including by CD4 + T cells, B cells, neutrophils and macrophages, was similarly decreased in mice with T cell-specific Pycard ablation compared with controls ( Fig. 1c,d) , and the expression of inflammatory cytokines and chemokines in the spinal cord was also significantly decreased (Fig. 1e) . Histopathological analysis showed decreased infiltrating immune cell accumulation and resultant demyelination in spinal cords of Asc f/− Lck-Cre mice compared with controls (Fig. 1f) . Together, these data indicate that deletion of Pycard from T cells greatly protects mice from the pathogenesis of EAE, with marked attenuation of disease severity. 
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A r t i c l e s ( Fig. 2c-g ). Together, these findings suggest that T cell-specific ASC deficiency does not affect T cell development, ex vivo T cell differentiation or primary MOG 35-55 -specific T cell priming in vivo.
T cell-intrinsic ASC is required for T H 17-mediated EAE Given that T cell-specific ASC deficiency attenuated EAE pathogenesis but not T cell priming, we chose to assess the pathogenic role of ASC-sufficient and ASC-deficient T H 1 cells and T H 17 cells by means of adoptive transfer into naive recipients. We found that wild-type recipients receiving cells from Asc f/− Lck-Cre mice that had been restimulated under T H 1 cell-promoting conditions developed similar disease as those receiving T H 1 cells from Asc f/+ Lck-Cre mice (Fig. 3a) . Analysis of the infiltrating mononuclear cell population in the brains of these mice showed no difference in the accumulation of CD4 + or CD8 + T cells, macrophages, neutrophils or B cells, consistent with the clinical scores (Fig. 3b) . Wild-type mice receiving cells from Asc f/− Lck-Cre mice restimulated under T H 17 cell-promoting conditions developed disease with reduced severity compared with that in mice receiving T H 17 cells from Asc f/+ Lck-Cre mice (Fig. 3c) . Surface staining of the brain mononuclear cell population showed that the numbers of CD4 + T cells, macrophages and neutrophils were also reduced in mice receiving ASC-deficient T H 17 cells compared with controls (Fig. 3d) . Histopathological analysis also reflected this reduced inflammatory-cell infiltration, along with reduced demyelination in mice receiving ASC-deficient T H 17 cells (Fig. 3e) Fig. 3 ), suggesting that ASC in CD4 + T H 17 cells is required for the effector stage of EAE development. Intracellular staining of brain-infiltrating mononuclear cells showed that the percentage and absolute number of both IL-17-and IFN-γ-secreting cells were decreased in mice receiving T H 17 cells from Asc f/− Lck-Cre mice compared with recipients of cells from Asc f/+ Lck-Cre mice (Fig. 3f) . Previous studies reported that during the development of EAE, IFN-γ and other pro-inflammatory cytokines (GM-CSF and TNF) in the spinal cord are produced almost exclusively by cells that produce IL-17 (ex-T H 17 cells) 19 , suggesting that the 
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Casp8 (Fig. 3g) . Taken together, these findings indicate that ASC-deficient T H 17 cells are markedly deficient in their production of key pro-inflammatory cytokines in the CNS.
To exclude the possibility that T cell-intrinsic ASC deficiency affects the migration of CD4 + T H 17 cells to the CNS, we adoptively transferred MOG 35-55 -primed T H 17 cells from Asc f/− Lck-Cre and Asc f/+ Lck-Cre mice into Rag1 −/− recipient mice. We found that T H 17 cells from mice with T cell-specific ASC deficiency egressed from the spleen and migrated to the CNS normally during the first wave of CNS infiltration (days 3 and 6 post-transfer) (Fig. 3h,i) . However, by day 10 after adoptive transfer, mice that had received T H 17 cells from Asc f/− Lck-Cre mice had fewer CD4 + T cells in the CNS than did recipients of cells from Asc f/+ Lck-Cre mice, which suggests that T H 17 cell survival and/or expansion in the CNS might be defective in the absence of ASC. In support of this, staining of the spinal cord with the proliferation marker Ki67 showed proliferating infiltrating CD4 + T cells after adoptive transfer of wild-type T H 17 cells that was markedly reduced in mice receiving ASC-deficient T H 17 cells (Fig. 3j) .
T H 17 cells actively release mature IL-1b
Given that ASC-deficient T H 17 cells did not proliferate or release proinflammatory cytokines-including IL-1β-in the CNS, we explored whether ASC might serve as an adaptor for inflammasome activation in T H 17 cells. During in vitro T H 17 cell differentiation, pro-IL-1β expression was strongly induced (Fig. 4a,b) . ATP is released by cells during stress and cell death, and it is abundant in the extracellular space in the CNS, where it also acts as a key excitatory neurotransmitter [20] [21] [22] . We thus speculated that the observed pro-IL-1β in T H 17 cells might undergo processing in response to stimulation with extracellular 
WT Pycard Fig. 4c-g ), although the amount of mature IL-1β produced by T H 17 cells was less than that produced by macrophages ( Supplementary  Fig. 4) . However, in ASC-and NLRP3-deficient T H 17 cells, IL-1β processing was completely abolished (Fig. 4c,d,g ). Caspase-1 is the prototypical IL-1β-converting enzyme in myeloid-lineage cells, and the regulation and function of the canonical caspase-1 inflammasome has been the subject of intense research. However, T H 17 cells deficient in both caspase-1 (Casp1 −/− ) and caspase-11 (Casp4 −/− ) showed only a moderate reduction in IL-1β production compared with controls (Fig. 4e,g ). Caspase-8 was recently identified as a noncanonical inflammatory caspase in myeloid-lineage cells, and it has been shown to be capable of processing pro-IL-1β (refs. [23] [24] [25] . This caspase-8-dependent activity was also shown to be important for T H 17 cell-mediated host defense 24 . Additionally, caspase-8 has been shown to have a critical nonapoptotic role in T cells [26] [27] [28] [29] [30] [31] . We thus speculated that in T H 17 cells, caspase-8 might participate in an ASC-dependent noncanonical inflammasome capable of processing pro-IL-1β. In response to ATP stimulation, IL-1β production was significantly reduced in T H 17 cells from Casp8 −/− Ripk3 −/− mice compared to those from Casp8 +/− Ripk3 −/− mice, implying a role for caspase-8 in T H 17 cells for the ASC-dependent processing of pro-IL-1β (Fig. 4f,g ). In support of this, peptide inhibitor of caspase-8 but not of caspase-1 specifically blocked IL-1β production in T H 17 cells (Fig. 4h) . Analysis of caspase-8 activation demonstrated that extracellular ATP indeed activated caspase-8 in a dose-dependent manner, and that this activation was substantially reduced in ASC-and NLRP3-deficient T H 17 cells (Fig. 4i) .
Given the finding that ATP stimulation of T H 17 cells induced processing of pro-IL-1β in an ASC-and caspase-8-dependent manner, we sought to further define the responsible molecular complex. Stimulation of T H 17 cells with ATP induced the recruitment of both caspase-8 and NLRP3, but not of caspase-1, to ASC, which suggests that an ASC-NLRP3-caspase-8 complex forms in response to ATP stimulation in T H 17 cells (Fig. 4j) .
T H 17-derived IL-1b supports cell survival in an autocrine manner We next sought to examine the mechanism by which T H 17 cellpolarizing conditions induce pro-IL-1β expression in T cells. As all helper T cell populations also require TCR stimulation for their initial activation and differentiation from the naive state, we first tested whether IL-1β expression was shared by the other T cell lineages. We found that T H 0, T H 1 and T H 17 cells all showed upregulated expression of Il1b and Nlrp3 mRNA (Fig. 5a,b) , a process that has been shown in myeloid cells to be strictly regulated and which is required for optimal inflammasome activation 32 . Additionally, amounts of Il18 mRNA were undetectable in T H 0 and T H 17 cells, and expression in T H 1 cells was very low (Fig. 5a) . ASC deficiency had no effect on the expression of Il1b, Il18 and Nlrp3 mRNA in T H 0, T H 1 and T H 17 cells (Fig. 5a) . ASC, which was located primarily in the nucleus of resting naive CD4 + T cells, translocated to the perinuclear area in response to TCR stimulation, reflecting what we and others have observed in mouse macrophages 33, 34 (Fig. 5c) . Further stimulation of these cells with ATP resulted in the formation of large perinuclear ASC specks, which are a well-described marker of inflammasome formation (Fig. 5c) . We further found that all three tested helper T cell lineages robustly activated caspase-8 and produced mature IL-1β after npg ATP treatment, and that both of these actions were abolished in the corresponding NLRP3-and ASC-deficient T cells (Fig. 5d,e) . Given these data indicating that inflammasome-mediated IL-1β production is not restricted to a particular CD4 + T cell lineage, which were in contrast to our observation that T cell-intrinsic ASC is specifically required for T H 17 cell-mediated neuroinflammation, we sought to examine the functional T H 17 cell-specific role of the ASCdependent inflammasome. We and others previously reported that IL-1R signaling mediates T H 17 cell maintenance through promotion of cell survival and proliferation 14, 15, 35 . Il1r1 expression was specifically induced during in vitro differentiation of T H 17 cells but not of T H 1 cells (Fig. 5f,g,i,j) . After MOG immunization, we detected IL-1R expression in IL-17 + CD4 + T cells but not in IFN-γ + CD4 + T cells (Fig. 5h,k) . We therefore hypothesized that IL-1β produced by T H 17 cells might act on IL-1R + T H 17 cells in an autocrine fashion. To test this hypothesis, we examined T H 1 cell and T H 17 cell survival after 8 h of ATP stimulation. Although both T H 1 cells and T H 17 cells showed caspase-8 activation and IL-1β production, ATP-treated T H 17 cells showed significantly increased cell survival compared with ATPtreated T H 1 cells, which was abrogated by deficiency of ASC, NLRP3 or IL-1β or by the addition of IL-1Ra (Fig. 5l) . These results suggest that T H 17 cell-derived IL-1β may act in an autocrine fashion to promote the survival and proliferation of T H 17 cells with high IL-1R expression (Supplementary Fig. 5 ).
CD4 + T cell-derived IL-1b is critical for EAE pathogenesis
To further examine the effects of T H 17 cell-derived IL-1β during EAE, we transferred CD4 + T cells from wild-type or Il1b −/− Il18 −/− mice into Rag1 −/− mice and then subjected the recipients to MOG immunization. We found that mice reconstituted with CD4 + T cells from Il1b −/− Il18 −/− mice were protected very well from EAE development compared with controls (Fig. 6a) . The expression of Il17a and Ifng mRNA, as well as of their target genes, was significantly decreased in the spinal cords of recipients of CD4 + T cells from Il1b −/− Il18 −/− mice compared with controls (Fig. 6b) . Inflammatory mononuclear cell infiltration in the CNS, including by CD4 + T cells, was also dramatically WT Il1b 
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A r t i c l e s reduced in recipients of CD4 + T cells from Il1b −/− Il18 −/− mice compared with controls (Fig. 6c) . Histopathological analysis of lumbar spinal cords from recipients of CD4 + T cells from Il1b −/− Il18 −/− mice showed reduced infiltrating immune cell accumulation and marked protection from demyelinating lesion development compared with controls (Fig. 6d) . As pro-IL-18 was only slightly induced in T H 1 cells and was not detected in T H 17 cells (Fig. 5a) , these results suggest that CD4 + T cell-derived IL-1β is probably critical for EAE pathogenesis. We indeed found that mice reconstituted with CD4 + T cells from Il1b −/− mice were almost completely protected from EAE development (Fig. 6e-g ), mirroring the results noted in recipients of CD4 + T cells from Il1b −/− Il18 −/− mice. Taken together, these results confirm that CD4 + T cell-derived IL-1β is critical for EAE pathogenesis. As an alternative to Rag1 −/− recipient mice, we generated mixed chimeras using bone marrow from Cd3e −/− mice together with bone marrow from either wild-type or Il1b −/− mice to assess the function of T cell-derived IL-1β. We reconstituted lethally irradiated wild-type mice with mixtures of bone marrow either from wildtype and Cd3e −/− mice or from Il1b −/− and Cd3e −/− mice. Six weeks after reconstitution, we immunized the mice with MOG peptide. The mice that received bone marrow from wild-type and Cd3e −/− mice developed EAE, whereas the recipients of bone marrow from Il1b −/− and Cd3e −/− mice were protected from EAE ( Supplementary  Fig. 6 ). These results independently validated the critical role of T cell-derived IL-1β in EAE pathogenesis. Given the potential role of IL-1β in promoting chemokine signals 17 , we completed a time-course analysis to examine how donor CD4 + T cells from Il1b −/− Il18 −/− mice were trafficked to the CNS after MOG immunization. The results indicated that T cellintrinsic IL-1β is dispensable for the first wave of T cell infiltration to the brain and spinal cord, as we observed no defect in CD4 + T cell egression from the spleen or migration to the CNS over the first 3-6 d after immunization (Fig. 7) . However, by day 10 after adoptive transfer, the number of CD4 + T cells in the CNS was dramatically decreased in recipients of CD4 + T cells from Il1b −/− Il18 −/− mice compared with recipients of wild-type cells (Fig. 7a) , which suggests that CD4 + T cell-derived IL-1β might be important for the survival and/or proliferation of CD4 + T cells in the CNS during EAE. In support of this, Ki67 immunofluorescent staining of spinal cord tissue showed a significant reduction in the number of proliferating CD4 + T cells in the absence of T cell-derived IL-1β compared with controls (Fig. 7c) . Flow cytometry indicated that 79% of CD4 + T cells with high IL-1R expression in the CNS of mice receiving wildtype CD4 + T cells were Ki67 + proliferating cells (IL-1R hi Ki67 + CD4 + T cells), whereas only 28% of CD4 + T cells with low IL-1R expression were Ki67 + cells. Numbers of these IL-1R hi Ki67 + CD4 + T cells were diminished in recipients of CD4 + cells from Il1b −/− Il18 −/− mice compared with recipients of wild-type cells (Fig. 7b) . Although previous studies reported that T cell-intrinsic IL-1R signaling is required for T H 17 cell survival and/or proliferation, our findings indicate that T cell-derived IL-1β is necessary to maintain the proliferation of CD4 + T cells in the CNS. In addition, between days 3, 6 and 10 of EAE development, mice that received wild-type CD4 + T cells showed marked induction of Ifng and Csf2 expression in the spinal cord, and Il17a and Il1r1 expression increased proportionally (Fig. 7d) . This progressive cytokine induction in the CNS during the course of EAE was abolished in mice that received CD4 + cells from Il1b −/− Il18 −/− mice, indicating the critical role of T cell-derived IL-1β in driving the production of pro-inflammatory cytokines to promote CNS inflammation (Fig. 7d) . IL-1 and IL-18 deficiencies seemed to have a much less marked effect on T cell percentages in the CNS than ASC deficiency did, which suggests that ASC might also be involved in non-inflammasome functions.
DISCUSSION
We used T cell-specific genetic deletion of the inflammasome adaptor molecule ASC and found that ablation of ASC in T cells conferred robust protection from EAE development in mice immunized with MOG , whereas it had no effect on the activation and proliferation of MOG -reactive T H 1 cells and T H 17 cells in the secondary lymphoid organs. Adoptive transfer of T H 1 cell-and T H 17 cell-polarized MOG -reactive cells showed that the protective effect of T cell ASC deficiency was specific to T H 17 cell-mediated neuroinflammation. This study demonstrates the critical role of the T cell-intrinsic inflammasome in T H 17 cell-mediated EAE pathogenesis.
T H 17 cell-polarized ASC-deficient T cells isolated from the brains of recipient mice were markedly defective in their ability to secrete key pro-inflammatory cytokines, including IL-17A, IFN-γ, GM-CSF, TNF and IL-1β. A report demonstrated that human CD4 + T cells also process IL-1β in an ASC-and NLRP3-dependent manner in response to HIV infection 36 . In addition, findings from the mouse EAE model have suggested that IL-1β stimulation actually induces the secretion of IL-17A, IFN-γ, GM-CSF and TNF from T H 17 cell-polarized brain-infiltrating cells 19 . We further found that T H 17 cells differentiated in vitro showed high expression of both IL-1R and pro-IL-1β, and that this pro-IL-1β could be processed and secreted in response to stimulation with extracellular ATP in a manner dependent on both ASC and NLRP3. Seeking to identify the caspase responsible for ATP-mediated IL-1β production by T H 17 cells in vitro, we found that whereas deficiency of caspase-1 or caspase-11 had minimal effect on IL-1β processing, IL-1β maturation and secretion were abrogated by genetic deletion of caspase-8. These data are surprising, as caspase-1 is expressed in T cells. The fact that pro-caspase-1 was not recruited to ASC upon ATP stimulation suggests that caspase-1 might be suppressed or sequestered from ASC by an unknown mechanism in mouse CD4 + T cells. Future studies are required to elucidate the molecular mechanism for the selective recruitment of caspase-8 to ASC in this context. An abundance of previously published reports support the notion that IL-1β is critical for the expansion and survival of MOG -reactive T cells in the secondary lymphoid organs 12, [14] [15] [16] 37, 38 . However, after immunizing Asc f/− Lck-Cre mice with MOG 35-55 , we did not observe any defect in antigen-dependent T H 17 cell or T H 1 cell polarization in the spleen, which suggests that IL-1β production by T cells is dispensable for MOG -induced priming in the periphery. It is therefore likely that IL-1β produced by macrophages and dendritic cells in the peripheral environment is sufficient to support initial T H 17 cell priming and expansion. However, we found that although ASC-deficient T H 17 cells were normal in their priming, egress from the spleen and first-wave infiltration of the CNS after adoptive transfer, they did not proliferate or induce recruitment of second-wave effector cell populations in the CNS. Furthermore, CD4 + T cells from Il1b −/− Il18 −/− mice also show marked defects in proliferation and effector function in the CNS, and Rag1 −/− mice reconstituted with CD4 + T cells from Il1b −/− mice were protected from EAE development. Taken together, and given the specific IL-1R expression in T H 17 cells, these results suggest that ASC-dependent production of IL-1β by T cells in the CNS might be necessary for effective T H 17 cell proliferation and effector cell recruitment.
Of particular note is the finding that both IL-17A-and IFN-γ-producing CD4 + T cell populations were reduced in the absence of T cell-intrinsic ASC. This finding mirrors a recent report that elegantly npg demonstrates the plasticity of T H 17 cells during EAE pathogenesis 19 . In that study, the authors used an IL-17 promoter-driven T H 17 cell lineage-tracing reporter system to show that after MOG immunization, classical IFN-γ-producing T H 1 cells were present at an ~1:1 ratio with respect to T H 17 cell-lineage IL-17A-producing cells in the draining lymph nodes. However, after arriving in the CNS, cells of the classical T H 1 cell lineage rapidly disappeared by day 15 after immunization. In addition, some T H 17 cells were converted to IL-17 − IFN-γ + cells, so-called ex-T H 17 cells, which actually became the dominant IFN-γ-producing cell population in the spinal cord. The IFN-γ-secreting ex-T H 17 cells continue to express IL-1R, whereas classical T H 1 cells do not. We observed dramatic defects in the production of both IFN-γ and IL-17A (as well as of the other inflammatory cytokines) by ASC-and IL-1-deficient CD4 + T cells in the brain, highlighting the critical role of T cell-derived IL-1β and consequent IL-1 signaling in T H 17 cells and ex-T H 17 cells during EAE. T H 1 cells, which lack IL-1R expression, cannot receive the important survival signal provided by T cell-derived IL-1β in the CNS, which may put them at a disadvantage relative to T H 17 cells and ex-T H 17 cells.
In summary, to our knowledge this study is the first to report that T cell intrinsic inflammasome activity drives IL-1β production via caspase-8 activation and is required for the pathogenic role of T H 17 cell-mediated CNS inflammation. Our findings lead us to speculate that chronic inflammation and tissue destruction in the CNS during EAE provide a prolonged danger signal, potentially in the form of extracellular ATP, to activate ASC-NLRP3-caspase-8-dependent IL-1β production in T cells. T cell-derived IL-1β in turn promotes the survival and/or expansion of IL-1R + T H 17 cells, and IL-1β stimulation of T H 17 cells also promotes secretion of key proinflammatory cytokines, resulting in amplification of the T H 17 cell-mediated inflammatory cascade. This novel model of the IL-1β-T H 17 cell axis yields possible new therapeutic strategies for inhibition of CNS inflammation.
METHODS
Methods and any associated references are available in the online version of the paper. 
